“Impact of Actinic Keratosis on patient-reported AK symptoms, emotions and functioning measured using Skindex-16, among patients with Actinic Keratosis administered tirbanibulin in real-world community practices across the U.S. (PROAK Study)” (2023) SKIN The Journal of Cutaneous Medicine, 7(3), p. s212. doi:10.25251/skin.7.supp.212.